» Articles » PMID: 30593135

Long-term Hormonal Therapy Resulting in Breast Cancer in Female-to-male Transsexual: Case Report

Overview
Specialty General Medicine
Date 2018 Dec 30
PMID 30593135
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Testosterone is important for the development of secondary sexual characteristics in female-to-male transsexuals. On the contrary, it can increase the risk of breast cancer.

Patient Concerns: We present a rare case of breast cancer in female-to-male transsexual patient after long-term hormonal therapy.

Diagnosis: Breast cancer in female-to-male transsexual patient.

Interventions: The patient underwent mastectomy and chemotherapy.

Outcomes: The patient had local recurrence of the disease and he underwent re-excision, radiotherapy and the tamoxifen treatment. After this treatment, the patient is in the remission from the disease.

Lessons: Breast cancer in transsexuals appears to be rare. However, there is a potential risk that testosterone exposure can increase the risk of developing breast cancer by the stimulation of breast tissue. There is limited published literature on the risk of breast cancer in transsexual patients.

Citing Articles

Aspects to consider regarding breast cancer risk in trans men: A systematic review and risk management approach.

Wahlstrom E, Audisio R, Selvaggi G PLoS One. 2024; 19(3):e0299333.

PMID: 38451995 PMC: 10919728. DOI: 10.1371/journal.pone.0299333.


Systematic Review on Gender-Affirming Testosterone Therapy and the Risk of Breast Cancer: A Challenge for Physicians Treating Patients from Transgender and Gender-Diverse Populations.

Pamulapati S, Conroy M, Cortina C, Harding E, Kamaraju S Arch Sex Behav. 2023; 53(5):1969-1980.

PMID: 38148450 DOI: 10.1007/s10508-023-02773-6.


Why Good Cancer Care Means Gender-Affirming Care for Transgender Individuals With Gendered Cancers: Implications for Research, Policy, and Practice.

Bybee S, Wilson C J Clin Oncol. 2023; 41(20):3591-3594.

PMID: 37224435 PMC: 10325736. DOI: 10.1200/JCO.22.01857.


Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening.

Fledderus A, Gout H, Ogilvie A, van Loenen D Breast. 2020; 53:92-100.

PMID: 32679529 PMC: 7375644. DOI: 10.1016/j.breast.2020.06.008.

References
1.
Brown G, Jones K . Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Res Treat. 2014; 149(1):191-8. DOI: 10.1007/s10549-014-3213-2. View

2.
Shao T, Grossbard M, Klein P . Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management. Clin Breast Cancer. 2011; 11(6):417-9. DOI: 10.1016/j.clbc.2011.06.006. View

3.
Corman V, Potorac I, Manto F, Dassy S, Segers K, Thiry A . Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation. Endocr Relat Cancer. 2016; 23(5):391-7. DOI: 10.1530/ERC-16-0057. View

4.
Gooren L, Bowers M, Lips P, Konings I . Five new cases of breast cancer in transsexual persons. Andrologia. 2015; 47(10):1202-5. DOI: 10.1111/and.12399. View

5.
Katayama Y, Motoki T, Watanabe S, Miho S, Kimata Y, Matsuoka J . A very rare case of breast cancer in a female-to-male transsexual. Breast Cancer. 2015; 23(6):939-944. DOI: 10.1007/s12282-015-0661-4. View